Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

VOLEX PLC AGM Information 2023

Jul 27, 2023

8012_agm-r_2023-07-27_0c1f3de6-5b77-4e13-830d-c1c1baee0d5d.html

AGM Information

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 4798H

Volex PLC

27 July 2023

27 July 2023

Volex plc

("Volex" or "the Company")

Results of Annual General Meeting

Volex plc (AIM: VLX), the global supplier of integrated manufacturing services and power products, is pleased to announce the results of its AGM, held earlier today, at which all resolutions were duly passed on a poll.

The total number of votes received on each resolution put to the AGM is as follows:

Resolution Percentage in Favour Votes For Votes Against Total  Votes Cast % of issued share capital voted Votes Withheld*
1. To receive the audited accounts of the Company for the financial year ended 2 April 2023 99.98% 107,231,818 22,663 107,254,481 59.28% 73,569
2. To approve the Remuneration Committee Report 95.72% 102,705,873 4,597,213 107,303,086 59.31% 24,964
3. To declare a final dividend of 2.6 pence per ordinary share for the financial year ended 2 April 2023 99.99% 107,322,754 3,567 107,326,321 59.32% 1,729
4. To re-elect Dean Moore as a Director 92.84% 99,617,479 7,684,408 107,301,887 59.31% 26,163
5. To re-appoint PricewaterhouseCoopers LLP as auditors of the Company 98.47% 105,678,991 1,637,789 107,316,780 59.32% 11,270
6. To authorise the Directors to determine the remuneration of the auditors 99.89% 107,132,446 121,184 107,253,630 59.28% 74,420
7. To authorise the Directors to allot shares in the Company pursuant to section 551 of the Companies Act 2006 ("2006 Act") 99.67% 106,973,727 349,291 107,323,018 59.32% 5,032
8. To authorise the disapplication of statutory pre-emption rights under section 570 of the Companies Act 2006 98.55% 105,766,306 1,557,217 107,323,523 59.32% 4,527
9. To authorise the further disapplication of statutory pre-emption rights under section 570 of the Companies Act 2006 in connection with an acquisition or specified capital investment 96.61% 103,675,355 3,641,119 107,316,474 59.32% 11,576
10. To authorise the Company to make purchases of its own shares in accordance with section 701 of the 2006 Act 99.96% 107,174,452 42,509 107,216,961 59.26% 111,089

Notes

*A vote withheld is not treated as a vote in law and is not counted in the calculation of the proportion of the votes cast for or against a resolution.

Resolutions 1 to 7 were ordinary resolutions, requiring a simple majority of votes cast to pass, while resolutions 8 to 10 were special resolutions, requiring at least 75% support to pass.

The total number of Volex shares in issue at 6.00 p.m. on 25 July 2023, being those eligible to be voted on at the AGM, was 180,925,266.

The full text of each of the resolutions is set out in the Notice of AGM, which is available on the Volex website (www.volex.com) on the "Shareholder Information" page in the Investor Relations section.

For further information please contact:

Volex plc +44 (0)7971 156 431
Nat Rothschild, Executive Chairman
Jon Boaden, Chief Financial Officer
Chris Bedford, Group General Counsel and Company Secretary
Peel Hunt LLP - Nominated Adviser & Joint Broker

Ed Allsopp

Tom Ballard

Ben Harrington
+44 (0)20 7418 8900
HSBC Bank plc - Joint Broker

Simon Alexander

Joe Weaving
+44 (0)20 7991 8888

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RAGNKOBBOBKDDOB